abagovomab 44
abciximab 40
abituzumab 25
abrilumab 25
actoxumab 23
adalimumab 22
aducanumab 17
afasevikumab 22
alacizumab_pegol 16
alemtuzumab 38
alirocumab 29
amatuximab 52
andecaliximab 29
anifrolumab 27
anrukinzumab 24
aprutumab 23
aprutumab_ixadotin 23
arcitumomab 29
ascrinvacumab 15
atezolizumab 17
atinumab 20
avelumab 18
basiliximab 47
bavituximab 48
begelomab 37
benralizumab 36
bevacizumab_beta 29
bezlotoxumab 23
bimagrumab 26
bleselumab 27
blinatumomab 44
blosozumab 35
bococizumab 23
brazikumab 20
brentuximab_vedotin 43
briakinumab 24
brodalumab 25
brolucizumab 31
brontictuzumab 31
burosumab 26
cabiralizumab 31
camrelizumab 17
canakinumab 29
cantuzumab_ravtansin 53
carlumab 21
carotuximab 35
cergutuzumab_amunaleukin2 35
cergutuzumab_amunaleukin 35
certolizumab_pegol 27
cetiximab 52
citatuzumab_bogatox 30
cixutumumab 36
clivatuzumab_tetraxetan 33
codrituzumab 36
conatumumab 21
concizumab 34
crenezumab 26
crizanlizumab 30
crotedumab 25
dacetuzumab 26
daclizumab 26
dalotuzumab 45
dapirolizumab_pegol 30
daratumumab 16
dectrekumab 13
demcizumab 35
denosumab 13
depatuxizumab 33
depatuxizumab_mafodotin 33
dezamizumab 27
dinutuximab 43
diridavumab 33
domagrozumab 19
drozitumab 29
duligotuzumab 21
durvalumab 18
dusigitumab 31
efalizumab 38
efungumab 35
eldelumab 22
elezanumab 27
elgemtumab 15
elotuzumab 22
emactuzumab 29
emapalumab 31
emibetuzumab 29
enavatuzumab 28
enfortumab_vedotin 15
enoblituzumab 24
enokizumab 28
enoticumab 25
ensituximab 46
eptinezumab 21
erenumab 30
etaracizumab 18
etrolizumab 25
evinacumab 25
evolocumab 28
farletuzumab 17
fasinumab 30
fezakinumab 33
fibatuzumab 23
ficlatuzumab 29
firivumab 40
flanvotumab 26
fletikumab 34
foralumab 19
foravirumab 18
fremanezumab 32
fresolimumab 21
fulranumab 26
futuximab 40
galcanezumab 25
ganitumab 35
gantenerumab 17
gemetuzumab 36
gemtuzumab2 35
gemtuzumab 39
gevokizumab 31
girentuximab 40
glembatumumab 27
glembatumumab_vedotin 27
guselkumab 28
ibalizumab 36
ibritumomab 47
icrucumab 19
idarucizumab 49
ifabotuzumab 23
imalumab 19
imgatuzumab 26
inclacumab 24
indatuximab_ravtansin 43
indusatumab 24
inebilizumab 34
intetumumab 21
iodine_girentuximab 33
ipilimumab 12
iratumumab 19
isatuximab 43
itolizumab 31
ixekizumab 39
labetuzumab_govitecan 33
lambrolizumab 32
lampalizumab 32
lanadelumab 19
landogrozumab 19
laprituximab 34
lebrikizumab 43
lendalizumab 28
lenzilumab 23
lifastuzumab_vedotin 27
ligelizumab 28
lilotomab 50
lirilumab 29
lodelcizumab 25
lokivetmab 28
lorvotuzumab_mertansin 31
lucatumumab 32
lumretuzumab 28
lupartumab 23
lutikizumab 23
margetuximab 47
milatuzumab 47
mirvetuximab 45
mirvetuximab_soravtansin 45
modotuximab 48
mogamulizumab 37
monalizumab 28
motavizumab 44
moxetumomab_pasudotox 36
namilumab 32
naratuximab 37
naratuximab_emtansin 37
narnatumab 23
navicixizumab2 33
navicixizumab 36
navivumab 41
necitumumab 14
nemolizumab 33
nesvacumab 20
nivolumab 18
obiltoxaximab 29
obinutuzumab 40
ocaratuzumab 29
ofatumumab 22
olaratumab 26
olokizumab 29
omalizumab 22
onartuzumab 26
ontuxizumab 39
opicinumab 17
orticumab 17
otelixizumab 43
oxelumab 15
ozanezumab 41
pamrevlumab 14
panobacumab 33
parsatuzumab 32
pasotuxizumab 23
pateclizumab 23
patritumab 33
pembrolizumab 32
perakizumab 25
pidilizumab 27
pinatuzumab_vedotin 19
plozalizumab 38
pogalizumab 28
polatuzumab_vedotin 24
ponezumab 43
prezalumab 18
pritoxaximab 50
quilizumab 23
racotumomab 39
radretumab 18
ralpancizumab 26
ramucirumab 16
ranevetmab 37
ranibizumab 29
refanezumab 33
remtolumab 22
rilotumumab 28
rinucumab 29
risankizumab 42
rituximab 34
rivabazumab 26
robatumumab 20
roledumab 38
romosozumab 31
rontalizumab 27
rosmantuzumab 32
rozanolixizumab 29
sacituzumab 36
sacituzumab_govitecan 36
samalizumab 32
sapelizumab 31
sarilumab 20
secukinumab 23
seribantumab 18
setoxaximab 53
sifalimumab 23
siltuximab 34
simtuzumab 32
sirukumab 16
solanezumab 29
solitomab 37
stamulumab 27
suptavumab 30
suvizumab 28
tabalumab 23
tadocizumab 22
tamtuvetmab 41
tanezumab 31
tarextumab 15
tavolixizumab 23
telisotuzumab 36
teplizumab 29
tesidolumab 33
tezepelumab 33
tigatuzumab 19
tildrakizumab 27
timolumab 20
tisotumab 17
tosatoxumab 50
tositumomab 46
tralokinumab 41
trastuzumab 25
tregalizumab 34
trevogrumab 16
ublituximab 40
urelumab 31
ustekinumab 31
utomilumab 32
vadastuximab 33
vadastuximab_talirin 33
vandortuzumab_vedotin 26
vantictumab 26
vanucizumab2 29
vanucizumab 44
varlilumab 20
vatelizumab 29
vedolizumab 34
veltuzumab 25
vesencumab 14
vorsetuzumab 32
vorsetuzumab_mafodotin 32
vunakizumab 45
xentuzumab 24
zatuximab 48
